A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies

Journal of Clinical Epidemiology

Volumn 47, Issue 2, 1994, Pages 183-189

  van Staa, Tjeerd Pieter ^a,b   Abenhaim, Lucien ^a   Leufkens, Hubert ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adverse drug reactions; Epidemiologic methods; Nonexperimental studies; Risk assessment

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADVERSE DRUG REACTION; ARTICLE; DRUG EXPOSURE; DRUG USE; INCIDENCE; METHODOLOGY; NETHERLANDS; PATIENT COMPLIANCE; PEPTIC ULCER; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SIMULATION; TIME;

ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIAS (EPIDEMIOLOGY); COMPUTER SIMULATION; DATABASES, FACTUAL; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGE; NETHERLANDS; PEPTIC ULCER; PHARMACIES; POISSON DISTRIBUTION; RISK FACTORS; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0027977018     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(94)90023-X     Document Type: Article

References (30)

1. The contribution of epidemiology to the study of drugs
2. Postmarketing surveillance methodologies
3. Use of automated data bases to study drug effects after marketing
4. Use of MEDICAID data for pharmacoepidemiology
5. MEDICAID data as a resource for epidemiologic studies: strengths and limitations
6. Record linkage studies for postmarketing drug surveillance: data quality and validity considerations
7. The role of record linkage in post-marketing drug surveillance.
8. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983
9. Principles of non-experimental assessment of excess risk, with special reference to adverse drug reactions
10. A biochemical basis for the gastrointestinal toxicity of non-steroid antirheumatoid drugs
11. The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal bleeding
12. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs
13. Nonsteroidal Anti-Inflammatory Drug Use and Death from Peptic Ulcer in Elderly Persons
14. Certain nonsteroidal antiinflammatory drugs and hospitalization for upper gastrointestinal bleeding
15. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND HOSPITAL ADMISSION FOR PERFORATED PEPTIC ULCER
16. Nonsteroidal anti-inflammatory drugs and hospitalization for gastro-esophageal bleeding in the elderly
17. Nonsteroidal anti-inflammatory drug use and hospitalization for peptic ulcer in elderly persons
18. Pharmacy records in pharmacoepidemiology: studies on antiinflammatory and antirheumatic drugs
19. Utilization patterns of nonsteroidal antiinflammatory drugs in an open Dutch population
20. The role of automated record linkage in the postmarketing surveillance of drug safety: a critique
21. A Monte Carlo primer for health physicists
22. The problem of non-compliance with drug therapy
23. Automated record linkage: A response to the commentary and letters to the editor
24. The future of automated record linkage for postmarketing surveillance: a response to Shapiro
25. Automated data bases used for pharmacoepidenmiologic research
26. Uninformed criticism of automated record linkage
27. Pharmacoepidemiology: The lessons learned; the challenges ahead